Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good luck on your venture!!! Perfectly understandable and best of luck with your journey.
Most importantly be contributing to the MYDX database...
That is because they attempt to be unbiased and look at ALL the facts to make the determination. Facts are with one good deal this company could travel upward fast...
Columbia?? That is interesting...
Agreed. Maybe this link will put reality back into some here. The 1Q will definitely do the same thing every quarterly has done. Show the company is moving in the direction outlined in the prior report. If you disagree with this direction then by all means get out. Otherwise be happen the progress is forward and goals are being slowly achieved.
http://www.businessinsider.com/guess-how-long-overnight-success-really-takes-2011-3
What exactly are you waiting for? I am not trying to be rude here but 2 mil is not a large share size in this stock. What is you PPS target?
“People generally see what they look for, and hear what they listen for.”
The irony that this comes from To Kill a Mockingbird is awesome. If you look for negativity in MYDX it can be found and positivity as well. The key is to look with open eyes at both and see which out weighs the other. If you are bias in either direction you will find what you seek...
I never invest long term to watch short term. A steady climb is far superior to an unwarranted run up.
Here is your reference to a "glucose meter" for cannabis. Allows patient and physician to track performance. Data gives insurance providers additional knowledge base for coverage analysis. I believe insurance company's to be one of the largest markets for the data.
Yes. Moving to NASDAQ is on the wish list but realistically just a long term goal. Anyone who has done the homework and knows business can see what is happening here. Idea was the start, during R&D all kinds of things stuck to the wall but CannaDx and the application morphed into the most viable choice as a first to market. With that accomplished, I believe they accurately determined the best course of action was to lean out, focus on the lead product and anything related to that core such as data and the pen. This method of consolidated effort is common in all large companies and something conventional finance looks for in startups. They want to see focus not chaos, a clear path that is being followed successfully. In a startup you have no historical data so what you do have needs to be solid. Missteps are not near as important as how they were addressed.
NASDAQ was never to happen within the year and the vape pen will have no affect on up listing when it does. One phone call easily confirmed that.
Must be the marketing department MYDX doesn't have anymore... lol
Right on. I can't use my normal brokers to find shares here. Plus I don’t daytrade much any more but when I do its generally a gimme and I am aggressive. Shorting helps provide liquidity so it has its place but you can do it with class. Plus this satisfies my gambling addiction and I win about 62% so much better vice.
When I bought this stock last fall and before I never even watched it until it hit what I thought top was. When it hit bottom this last time I decided to get serious but I could have not watched this time either, still just printing money for me but with all the new developments exciting times...
Its ok to be new. You will also learn in time there are many ways to profit in the market. Not understanding why you are in a stock is a poor way to start. I have made 20 times 40k on MYDX long.
Hahaha didn't go down much. Maybe you just looked at the stock today but its been hanging around here for a while now just popping up when newbies come across some news article. But it doesn't bother me still setting at HUGE profit...
The smart pen is not considered drug paraphernalia for one unless your using it for that purpose. It can be used with therapeutics other than marijuana for and NASDAQ doesn't give a rats a$$ about it any of it either way. In addition, while some may use beer for medication that is not its intended purpose. Alcohol content is regulated to a certain level and it is the only thing effecting your "therapeutic value". Marijuana on the other hand has an entourage effect from multiple chemicals working together. Each strain has differing effects on different people so yes the smart pen has value. Another first to market, keeps with the cannabis market focus, additional information uploading to the application and a less expensive way to continue marketing and creating brand awareness. The oils are becoming more common for the medical user for many reasons and this captures that market inexpensively. Brilliant if you know the market and think about it.
Some of what you say was correct about big Pharmaceutical companies. But they have mostly lost that fight and are now on different fronts. One being regulation, they know it is not cost effective for smaller companies to deal with these type of regulatory requirements. Companies that have something are being swallowed up others will be bankrupted. They are also trying to turn something that comes out of the ground into a patented product. Once the Human Genome project was almost finished companies started mapping everything. Now cannabis is mapped will be specifically bred for whatever combination maximizes the effect on that ailment and that DNA profile will be patented. Ironically, this should just show a greater need for data from the MYDX application allowing consumers to profile their medication. It would be great to do this with existing medications. How many times has your doctor given you something that made you feel worse? It would be nice to check the app and discover many had the same results and say no to it instead of thinking it was just you.
No is nothing close to what the post says.
Nothing will change with taking drugs or anything else across the border illegally. Federal policy change will not effect that. Legalization of marijuana will take all the profit out of illegal marijuana which will stop it though.
It will gain approval but in steps as it has been gaining ground all along. Cash is king and these states have seen the cash pour in. Now others want a piece and you will see a critical tipping point here soon and Canada could cause that to happen sooner than later. Federal government will not stand in the way and they are already standing down. That coupled with a President that wants to look good in the eyes of the people majority will rule on this in the near term. As for Lil' Kim, China has and will continue to rein him in because they don't want the US getting involved.
Again you are using 4 month old figures. Second your understanding of the information is inadequate. I hope for the last time, there is no question as to whether MYDX is or is not in the "MJ sector". They are in the sector of course but they have nothing to do with the purchase or sale of marijuana. THAT is the Federal stipulation. Otherwise common sense tells you the power company would not be able to obtain financing because they supply power to a grower. Last, if Yazbeck likes to manipulate share price through PR why has he not taken your professional advice and done so this month? When dealing with conventional finance and public companies there are rules. If it is necessary and financing is obtained information will be released accordingly.
You are correct. It can be sold as a market research tool for companies retailing these products and will be marketed to the user as a "step counter" for their vape products. Multiple data markets one application... I think some other startups used this process to generate revenue. Little companies like Microsoft.
More simple words with no substance.
This proves that MYDX is capable to take a concept to fruition in under 4 years. There are several large companies that cannot achieve this. In addition, the app is meant to become your own personal strain library, allowing you to take notes, pictures and to rate your different cannabis flowers and experiences. The app has been accumulating data during the last 3 years as well. CDXlife has tested over 500 strains in-house via GC and MyDx to verify accuracy against commercial testing equipment. Then verify it to independent data from their partnered laboratories. This application can be used with or without the MYDX analyzer to continually gather crowd-sourced data regardless of ability to obtain the device. The application is being used to sell the device, not the other way around.
MYDX through PARTNERSHIPS is now creating new revenue streams expanding the data market place for its app. R&D is ongoing as well as marketing, branding and sales. This was discussed in previous filings and is coming to fruition.
With so many goals achieved in such a short time I dare anyone to match this companies record to other OTC investments. MYDX has used every investors recourses to move the company forward, escape debt, increase revenue and position for future growth successfully. It is obvious MYDX is in full control of it's destiny.
This article addresses many repeat questions on this board, including why do they not release every little piece of company information when certain posters here request it.
https://mgretailer.com/mydx-cannabis-lab-testing/
This article confirms the MYDX mission statement and where they are and what is in store for the future.
http://diginomica.com/2016/08/05/the-mission-of-mydx-put-chemicals-testing-in-the-hands-of-consumers/
private unpaid video of the device in action.
Your simple question deserves a simple to understand answer. You will see them when you need to no sooner. Toxic debt is only relevant to a company holding it. Your living it the past there.
I have seen you on another board and knew what your alias stands for. Thank you for your service Sir! A good friend of mine is a veteran and now lobbies for veterans affairs in DC. Maybe you can validate his statement when I presented him with information about the MYDX device. His words: " This device has extraordinary possibilities in our armed services. " He went on to say the military has protocols for field provisions and acquiring them in extreme circumstances but no means of verification in combat. He is no light weight either and has many appropriations committee contacts. In fact, a few months back while in DC lobbying for JASTA had lunch with Mr. McCain and discussed this very device and the potential applications.
This board has some tenacious investors with excellent investigative skills both pro and con. I honestly like the accurately portrayed con's most. It has forced me to dig even deeper into this company along with many others for my own research. This is not the only science of its kind but it is the first to be put to market. Those of you that do not know Bill Gates do not understand why he sought out and invested in this technology. He understands full well what first to market does for a company and an industry.
This is a ridiculous post or you have no idea whatsoever about institutional financing and federal banking regulations. I have interests in dispensaries and part of the reason is my knowledge of finance. This is why Yazbeck has a separate investment business. I have bank financing for all the buildings and equipment. You know how? I created a holding company that purchases everything and leases it to my other business interests. How this vehicle works is far to complex to discuss here but anyone who actually knows business will understand what I am talking about. This is not a arguable opinion, it is a fact.
There are so many partner and buy out prospects for technology it is incredible. The hard part is done here and Mr Yazbeck and institutional investors know this.
I leave you with this "opinion". Partnering is a far more viable solution for the data accumulation side of the MYDX product. It has been in labs from the beginning being tested against commercial laboratory equipment for accuracy. These same labs test strains for regulatory compliance in multiple grow facilities in various states. These labs have been testing for medical use primarily because recreational use is relatively recent and less common until last few years. MYDX's database is invaluable as a unique strain identifying tool for patients coupled with recording the “entourage effect” within that cannabis profile. The only way to compile the data is over time and MYDX has a lead on many because in the medical world you need to submit applications to do studies with marijuana and participants are limited. No the data is not near as good as a formal clinical research program done in a controlled environment obviously. But thanks to the recent genomic data that has grown at a rapid rate around the cannabis genome many strains already have known identifiable markers that distinguish them from other strains just as DNA in humans. What MYDX is does is analyze the users strain, chemical properties within the strain and the results of effects on that user to create a profile. Everyone is different no doubt but after enough data is entered for that strain by enough users it will start to develop a pattern of results for specific ailments form the strain. This is important in more ways than one. Recording the strains properties, even though not multi-million dollar lab results, is like getting a partial finger print. When compared to complete profile data you can get extremely close verifiable identification if not dead on. Then the various user data creates an association with that strain clinical studies will be able to identify. How does this help? It will give any clinical study an educated place to start regarding whatever results the study is hoping to achieve. Formal clinical studies are very expensive and time consuming so this data could help save money and time by aiding to single out strain candidates based on known data. It pays to note this is only the first edition. As MYDX is used it will continue to be refined. There are existing companies such as Agilent Technologies that MYDX could be very interesting too.
Everything in this post is incorrect, untruthful or just fabricated. This company has nothing to do with the purchase or sale of marijuana. They can be financed by any lender. Moreover MYDX already has been given several huge lines of credit, one of which is a fortune 100 company for up to 120 days. MYDX has everything needed to obtain conventional financing including Mr. Yazbeck's personal backing of the company.
Now your getting warmer...
There is a big difference in PR and Marketing in business. I understand the OTC does not realize the difference but corporate America does. This company has products that need to be marketed to generate revenue. Because there are additional regulations to a public company it is wise to use a company experienced in branding, marketing and public relations. Real companies do this regularly to drive sales and brand awareness not to satisfy the need for minority share holders short term gains but to increase long term company revenues.
Regardless if you are trying to evaluate anything on 4 month old data you may be confused...
I confuse nothing. My 750K positive balance here tells me so.
This made me curious as well.
http://www.reuters.com/article/us-arxis-moves-idUSKCN0Q42N820150730
Arxis Capital Group LLC
Arxis Capital Group LLC is an electronic trading firm specializing in the automated market making of global securities. Its goal is to develop and utilize technological innovations that intelligently analyze data in order to deliver liquidity across all asset classes. It is headquartered in New York, with operations in London and Hong Kong. Arxis Capital was formed in 2014 by senior equities trading executives from Bank of America Merrill Lynch's Global Market Making Business.
MYDX has only started releasing news. This is why a company was hired for marketing in the 1 quarter for the next 12 months.
As does every 10K on the planet... This is news why???
Have you forgotten about Yazbeck investments? Even if MYDX could not attract financing, which is a false statement, Yazbeck investments could. But MYDX already has received investment in the form of credit. They can order and sell without any "out of pocket" for up to 120 days. R&D is still moving forward. Data is being sold for revenue. Most services are on a contractual basis so when the service is completed and generating revenue there is a 60+ day period before payment must be made. This type of credit is what conventional venture capital finance looks for to extent credit to new businesses.